Holen Sie sich die Stockscreener-App
1.24
8.82%
-0.12
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Codexis Inc (4QK.DU) interactive stock chart - Yahoo Finance Australia
Codexis CFO Georgia Erbez sells $8,619 of common stock - Investing.com
President and CEO Alison Moore sells $8,619 in Codexis stock - Investing.com
President and CEO Alison Moore sells $8,619 in Codexis stock By Investing.com - Investing.com South Africa
Form 4 Codexis Inc: Alison Moore (Director, President and CEO) For: 12 October - Investing.com Nigeria
An $8.62K share sale proposed by Codexis (CDXS) officer Georgia Erbez involves a vested stock grant. - Stock Titan
Officer Alison Moore proposes selling 6,335 Codexis (Nasdaq: CDXS) shares. - Stock Titan
Codexis (CDXS) Partners on Stereo-Defined siRNA Fragment Synthes - gurufocus.com
Codexis partners with siRNA innovator on enzyme synthesis By Investing.com - Investing.com Canada
Codexis partners with siRNA innovator on enzyme synthesis By Investing.com - Investing.com Nigeria
Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA - Yahoo Finance Australia
Codexis Enters into an Agreement with Pioneering siRNA Drug - GlobeNewswire
Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA - Yahoo Finance
Codexis (NasdaqGS:CDXS) Stock Forecast & Analyst Predictions - Simply Wall Street
Codexis at Cantor conference: enzymatic RNA manufacturing gains ground By Investing.com - Investing.com Canada
Codexis (CDXS) Q2 2026 Earnings: Loss Narrower Than Expected, Shares Decline 2.03%Revenue Per Share - vinanet.vn
Codexis (CDXS) Slides 3.61% to $1.60: Key Support Levels Under ScrutinyBollinger Expansion - vinanet.vn
Codexis (CDXS) Slides 3.61% to $1.60: Key Support Levels Under ScrutinyIV Rank - siam.in
Codexis to Participate in Cantor Global Healthcare Conference 2026 - GlobeNewswire
Codexis Management Will Participate in a Sept. 10 Fireside Chat - Stock Titan
Codexis to Participate in Cantor Global Healthcare Conference 2026 - Yahoo Finance
Codexis (CDXS) Financial Results: The Available Earnings Metric Delivers a Beat in the Latest Reading; Session Move - vinanet.vn
Codexis (CDXS) Financial Results: The Available Earnings Metric Delivers a Beat in the Latest Reading; Session Move - dars.gov.et
Codexis (CDXS) Q2 2026 Earnings Call Transcript - The Globe and Mail
CDXS Maintained by Piper Sandler -- Price Target Lowered to $8.0 - GuruFocus
CDXS Looks 39.1% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
CDXS Looks 39.1% Undervalued on GF Value™ - GuruFocus
Codexis (NASDAQ:CDXS) Cut to "Sell" at Wall Street Zen - MarketBeat
Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Codexis (CDXS) investor Laurence Lytton discloses 5.2% beneficial stake in shares - Stock Titan
Codexis earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Codexis, Inc. Stock 12‑Month Price Target Cut to $6.5, Implies 339% Upside - TradingView
Codexis Inc (CDXS) (Q2 2026) Earnings Call Highlights: Biocatalysis Growth and ECO Synthesis ... - finance.yahoo.com
Codexis Inc (CDXS) (Q2 2026) Earnings Call Highlights: Biocataly - GuruFocus
Codexis, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
CDXS Looks 40.1% Undervalued on GF Value™ Amidst Challenging Fun - GuruFocus
Codexis narrows Q2 loss, raises $25M to fund GMP expansion - scanx.trade
Codexis Affirms FY26 Sales Guidance Range Amid Stable Outlook - scanx.trade
Transcript : Codexis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
Codexis (NASDAQ:CDXS) Issues Earnings Results - MarketBeat
Codexis Q2 Earnings Call Highlights - MarketBeat
Codexis Q2 Earnings Call Highlights - Yahoo Finance
CDXS: Q2 2026 saw revenue of $14.9M, margin gains, new financing, and major ECO Synthesis advances - tradingview.com
Earnings call transcript: Codexis beats Q2 2026 estimates as shares rise after hours - Investing.com
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
How Did Codexis Inc (CDXS) Perform in Q2? EPS at -0.14, Revenue Beats Estimates; GF Score: 49/100 - GuruFocus
Codexis, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
CODEXIS ($CDXS) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Codexis: Q2 Earnings Snapshot - marketscreener.com
Codexis: Q2 Earnings Snapshot - 10TV
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):